ClinicalTrials.gov
public full text
Public Domain
The Identification of Novel Prognostic Markers in Melanoma
The purpose of this project is to analyze tumour tissue from a group of subjects with malignant melanoma, who have been treated at the Royal Marsden Hospital.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma#1047328
- Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma#967468
- Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma#890446
- A Biomarker Screening Protocol for Participants With Solid Tumors#184830
- SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access#1102527
Record · ID 834101
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive